/DGEN

DGEN Stock - Deltagen Inc.

Q: What is the analyst price target for DGEN?

Analyst price target information is not currently available for DGEN.

Q: What is DGEN's market cap?

Market capitalization information is not currently available for DGEN.

Healthcare|Medical - Instruments & Supplies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DGEN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2009

FY2010

FY2012

FY2013

FY2014

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta4.20

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2014	FY2013	FY2012	FY2010	FY2009
Revenue	$263,000	$1.02M	$1.05M	$1.99M	$1.36M
Gross Profit	$77,000	$660,000	N/A	N/A	N/A
Gross Margin	29.3%	64.6%	0.0%	0.0%	0.0%
Operating Income	$77,000	$112,000	$-53,000	$-694,000	$-703,000
Net Income	$76,000	$-4,418,000	$-1,165,000	$-685,000	$-687,000
Net Margin	28.9%	-432.3%	-110.5%	-34.5%	-50.6%
EPS	$0.00	$0.00	$0.00	$0.00	$0.00

Company Overview

Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.

Visit Website

Frequently Asked Questions about DGEN

What is DGEN's current stock price?

Deltagen Inc. (DGEN) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for DGEN?

No analyst price targets are currently available for this stock.

What sector is Deltagen Inc. in?

Deltagen Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is DGEN's market cap?

Deltagen Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does DGEN pay dividends?

No, Deltagen Inc. does not currently pay a dividend to shareholders.